Literature DB >> 22084250

Elucidation of acid-induced unfolding and aggregation of human immunoglobulin IgG1 and IgG2 Fc.

Ramil F Latypov1, Sabine Hogan, Hollis Lau, Himanshu Gadgil, Dingjiang Liu.   

Abstract

Understanding the underlying mechanisms of Fc aggregation is an important prerequisite for developing stable and efficacious antibody-based therapeutics. In our study, high resolution two-dimensional nuclear magnetic resonance (NMR) was employed to probe structural changes in the IgG1 Fc. A series of (1)H-(15)N heteronuclear single-quantum correlation NMR spectra were collected between pH 2.5 and 4.7 to assess whether unfolding of C(H)2 domains precedes that of C(H)3 domains. The same pH range was subsequently screened in Fc aggregation experiments that utilized molecules of IgG1 and IgG2 subclasses with varying levels of C(H)2 glycosylation. In addition, differential scanning calorimetry data were collected over a pH range of 3-7 to assess changes in C(H)2 and C(H)3 thermostability. As a result, compelling evidence was gathered that emphasizes the importance of C(H)2 stability in determining the rate and extent of Fc aggregation. In particular, we found that Fc domains of the IgG1 subclass have a lower propensity to aggregate compared with those of the IgG2 subclass. Our data for glycosylated, partially deglycosylated, and fully deglycosylated molecules further revealed the criticality of C(H)2 glycans in modulating Fc aggregation. These findings provide important insights into the stability of Fc-based therapeutics and promote better understanding of their acid-induced aggregation process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22084250      PMCID: PMC3256859          DOI: 10.1074/jbc.M111.297697

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Folding mechanism of the CH2 antibody domain.

Authors:  Matthias J Feige; Stefan Walter; Johannes Buchner
Journal:  J Mol Biol       Date:  2004-11-12       Impact factor: 5.469

2.  Alternatively folded states of an immunoglobulin.

Authors:  J Buchner; M Renner; H Lilie; H J Hinz; R Jaenicke; T Kiefhabel; R Rudolph
Journal:  Biochemistry       Date:  1991-07-16       Impact factor: 3.162

3.  Acid-induced folding of proteins.

Authors:  Y Goto; L J Calciano; A L Fink
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  'Molten-globule state': a compact form of globular proteins with mobile side-chains.

Authors:  M Ohgushi; A Wada
Journal:  FEBS Lett       Date:  1983-11-28       Impact factor: 4.124

5.  A thermodynamic study of cooperative structures in rabbit immunoglobulin G.

Authors:  V M Tischenko; V P Zav'yalov; G A Medgyesi; S A Potekhin; P L Privalov
Journal:  Eur J Biochem       Date:  1982-09-01

6.  Phase diagram for acidic conformational states of apomyoglobin.

Authors:  Y Goto; A L Fink
Journal:  J Mol Biol       Date:  1990-08-20       Impact factor: 5.469

7.  Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.

Authors:  M H Tao; S L Morrison
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

Review 8.  Structural description of acid-denatured cytochrome c by hydrogen exchange and 2D NMR.

Authors:  M F Jeng; S W Englander; G A Elöve; A J Wand; H Roder
Journal:  Biochemistry       Date:  1990-11-20       Impact factor: 3.162

9.  Mechanism of acid-induced folding of proteins.

Authors:  Y Goto; N Takahashi; A L Fink
Journal:  Biochemistry       Date:  1990-04-10       Impact factor: 3.162

10.  A high-throughput UPLC method for the characterization of chemical modifications in monoclonal antibody molecules.

Authors:  Nicole Stackhouse; Amanda K Miller; Himanshu S Gadgil
Journal:  J Pharm Sci       Date:  2011-07-24       Impact factor: 3.534

View more
  39 in total

1.  Monoclonal Antibodies Follow Distinct Aggregation Pathways During Production-Relevant Acidic Incubation and Neutralization.

Authors:  Thomas Skamris; Xinsheng Tian; Matthias Thorolfsson; Hanne Sophie Karkov; Hanne B Rasmussen; Annette E Langkilde; Bente Vestergaard
Journal:  Pharm Res       Date:  2015-11-12       Impact factor: 4.200

2.  Weak protein interactions and pH- and temperature-dependent aggregation of human Fc1.

Authors:  Haixia Wu; Kristopher Truncali; Julie Ritchie; Rachel Kroe-Barrett; Sanjaya Singh; Anne S Robinson; Christopher J Roberts
Journal:  MAbs       Date:  2015-08-12       Impact factor: 5.857

3.  Rational design of therapeutic mAbs against aggregation through protein engineering and incorporation of glycosylation motifs applied to bevacizumab.

Authors:  Fabienne Courtois; Neeraj J Agrawal; Timothy M Lauer; Bernhardt L Trout
Journal:  MAbs       Date:  2016       Impact factor: 5.857

4.  Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress.

Authors:  Takahiko Ito; Kouhei Tsumoto
Journal:  Protein Sci       Date:  2013-09-30       Impact factor: 6.725

5.  Protein aggregation and mitigation strategy in low pH viral inactivation for monoclonal antibody purification.

Authors:  Weixin Jin; Zizhuo Xing; Yuanli Song; Chao Huang; Xuankuo Xu; Sanchayita Ghose; Zheng Jian Li
Journal:  MAbs       Date:  2019-09-02       Impact factor: 5.857

6.  A stepwise mechanism for aqueous two-phase system formation in concentrated antibody solutions.

Authors:  Bradley A Rogers; Kelvin B Rembert; Matthew F Poyton; Halil I Okur; Amanda R Kale; Tinglu Yang; Jifeng Zhang; Paul S Cremer
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-23       Impact factor: 11.205

7.  Aggregation mechanism of an IgG2 and two IgG1 monoclonal antibodies at low pH: from oligomers to larger aggregates.

Authors:  Paolo Arosio; Simonetta Rima; Massimo Morbidelli
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

8.  High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation.

Authors:  Mohammad A Alsenaidy; Jae Hyun Kim; Ranajoy Majumdar; David D Weis; Sangeeta B Joshi; Thomas J Tolbert; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2013-09-24       Impact factor: 3.534

9.  Engineered aglycosylated full-length IgG Fc variants exhibiting improved FcγRIIIa binding and tumor cell clearance.

Authors:  Migyeong Jo; Hyeong Sun Kwon; Kwang-Hoon Lee; Ji Chul Lee; Sang Taek Jung
Journal:  MAbs       Date:  2017-12-07       Impact factor: 5.857

10.  Optimization of Enzymatic Antibody Fragmentation for Yield, Efficiency, and Binding Affinity.

Authors:  Andrew W L Kinman; Rebecca R Pompano
Journal:  Bioconjug Chem       Date:  2019-01-28       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.